On Thursday, Shares of Dollar General Corp. (NYSE:DG), lost -3.18% to $74.27.
Dollar General Corporation declared that the Company’s Board of Directors has declared a quarterly cash dividend of $0.22 per share on the Company’s common stock. The dividend will be payable on September 30, 2015 to shareholders of record at the close of business on September 16, 2015.
Dollar General Corporation, a discount retailer, provides various merchandise products in the southern, southwestern, midwestern, and eastern United States. The company offers consumable products, counting paper and cleaning products comprising paper towels, bath tissues, paper dinnerware, trash and storage bags, and laundry and other home cleaning supplies; packaged food products, such as cereals, canned soups and vegetables, condiments, spices, sugar, and flour; perishables compriseing of milk, eggs, bread, frozen meals, beer, and wine; snacks that comprise candies, cookies, crackers, salty snacks, and carbonated beverages; health and beauty products, such as over-the-counter medicines, in addition to soap, body wash, shampoo, dental hygiene, and foot care products; pet products, which comprise pet supplies and pet food; and tobacco products.
Shares of SanDisk Corporation (NASDAQ:SNDK), inclined 6.75% to $52.85, during its last trading session.
SanDisk Corporation, unveiled three new reference architectures for VMWare Virtual SAN™ 6 utilizing solid-state drives (SSD) and Fusion ioMemory PCIe application accelerators. When coupled with VMware Virtual SAN 6, SanDisk’s PCIe and SSD-based solutions allow customers to deploy business critical applications, databases, virtual desktops and other IT workloads with less effort, while gaining exceptional performance on VMware’s hyper-converged and cost-effective VMware Virtual SAN software-defined storage infrastructure.
“SanDisk is addressing the challenges of latency and cost efficiency in the data center with our all-flash VMware Virtual SAN reference architectures, which allow customers to expand the workloads they can run on all-flash and hybrid-flash storage at significantly lower costs,” said John Scaramuzzo, senior vice president and general manager, Enterprise Storage Solutions, SanDisk. “These new solutions are prime examples of how SanDisk continues to collaborate with VMware. We look forward to working with our mutual partners to assist customers experience the noteworthy benefits of the flash-transformed, software-defined data center.”
SanDisk Corporation designs, develops, manufactures, and markets data storage solutions in the United States and internationally. The company offers removable cards, which are used in various applications and consumer devices, counting digital cameras, camcorders, smartphones, tablets, and eReaders under the SanDisk Ultra, SanDisk Extreme, and SanDisk Extreme PRO brands; and embedded products that are used in mobile phones, tablets, notebooks, and other portable and wearable devices, in addition to in automotive and connected home applications under the brand name iNAND.
Finally, Fluidigm Corporation (NASDAQ:FLDM), ended its last trade with -3.15% loss, and closed at $11.38.
Fluidigm Corporation declared commercial availability of a new high throughput single-cell mRNA sequencing workflow for its C1TM system to enable large-scale studies to characterize heterogeneous samples. This validated workflow comprises a new advanced integrated fluidic circuit (IFC) and reagent kit that significantly enhances throughput and ease-of-use, while simultaneously decreasing the cost of preparation and sequencing (by maximizing sequencer capacity) on a per-cell basis. The C1 mRNA Seq HT application is the first and only commercial product to address large single-cell studies and is accessible recently.
Researchers can apply the new HT workflow to explore heterogeneity in fields such as cancer, neuroscience, stem cell biology, and immunology to understand how the underlying cellular mechanisms impact biological processes or disease progression. This new offering is a complete solution that enables scientists to deeply explore the diversity of cell subpopulations, quickly discover novel or rare cell types, and enhance the statistical sample size to better estimate biological variation between similar cell types.
The C1 mRNA Seq HT IFC can capture up to 800 cells at a time, and employs a new protocol to facilitate two runs – or 1600 cells – a day. Additionally, the IFC features two cell-loading inlets to facilitate “case as compared to controls” studies, allowing users more flexibility in their experimental design. The assay protocol enables on-IFC multiplexing and cell pooling that provides users with a streamlined workflow. The complete workflow reduces customer library preparation costs by about 85% when contrast to the original C1 mRNA Seq IFC costs, while maintaining the automation and reproducibility of the C1 platform.
Fluidigm Corporation creates, manufactures, and markets technologies and life science tools focused on the exploration and analysis of single cells, in addition to the industrial application of genomics.
DISCLAIMER:
This article is published by www.wsnewspublishers.com. The Content included in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.
All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.
Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.
Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified through the use of such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should/might occur.
